Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DNDi: 100 years of Chagas disease, but R&D still lacking

This article was originally published in Scrip

Executive Summary

On the 100th anniversary of the discovery of Chagas disease, a new global campaign to encourage awareness and research has been launched by the Drugs for Neglected Disease initiative (DNDi). The disease, which was discovered in 1909 by the Brazilian doctor Carlos Chagas, is caused by the parasite Trypanosoma cruzi, which is transmitted to humans by the triatomine bugs which can hide in the cracks of poorly built homes.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC003464

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel